Tissue Kallikrein Mediates Pro-Inflammatory Pathways and Activation of Protease-Activated Receptor-4 in Proximal Tubular Epithelial Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Tissue kallikrein (KLK1) expression is up-regulated in human diabetic kidney tissue and induced by high glucose (HG) in human proximal tubular epithelial cells (PTEC). Since the kallikrein-kinin system (KKS) has been linked to cellular inflammatory process in many diseases, it is likely that KLK1 expression may mediate the inflammatory process during the development of diabetic nephropathy. In this study, we explored the role of KLK1 in tubular pro-inflammatory responses under the diabetic milieu. Recombinant KLK1 stimulated the production of inflammatory cytokines in PTEC via the activation of p42/44 and p38 MAPK signaling pathways. Molecular knockdown of endogenous KLK1 expression by siRNA transfection in PTEC attenuated advanced glycation end-products (AGE)-induced IL-8 and ICAM-1 productions in vitro. Interestingly, exposure of PTEC to KLK1 induced the expression of protease-activated receptors (PARs). There was a 2.9-fold increase in PAR-4, 1.4-fold increase in PAR-1 and 1.2-fold increase in PAR-2 mRNA levels. Activation of PAR-4 by a selective agonist was found to elicit the pro-inflammatory and pro-fibrotic phenotypes in PTEC while blockade of the receptor by specific antagonist attenuated high glucose-induced IL-6, CCL-2, CTGF and collagen IV expression. Calcium mobilization by the PAR-4 agonist in PTEC was desensitized by pretreatment with KLK1. Consistent with these in vitro findings, there was a markedly up-regulation of tubular PAR-4 expression in human diabetic renal cortical tissues. Together, these results suggest that up-regulation of KLK1 in tubular epithelial cells may mediate pro-inflammatory pathway and PAR activation during diabetic nephropathy and provide a new therapeutic target for further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A previous study suggested that Klk1 may induce inflammatory cytokines in human RTECs, at least in vitro [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
In the citing paper
“Additionally, Klk1 activates protease-activated receptors (PAR) such as PAR4 to trigger the release of inflammatory mediators from RTEC [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
In the citing paper
“Klk1-mediated activation of PAR4 induces cytokine production and prevents apoptosis in RTEC, known as the bradykinin-independent pathway [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744 · cited 1×
“In most studies, KLK1 targets B2R via the formation of bradykinin (BK) [49] and we previously demonstrated this phenomenon in HG stimulated PTEC [9] although KLK1 was recently shown to directly activate B2R in the absence of kininogen both in vitro [50] and in vivo [51] in other cell types.”
BackgroundCellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078 · cited 3×
“The increased PAR-4 expression after KLK1 incubation is consistent with the irreversible nature of PAR activation, in which the activating protease cleaves the extracellular N terminus to expose the tethered ligand, such that a fresh supply of the receptor is required to sustain the action of its agonist [20].”
BackgroundInflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072 · cited 2×
“Increased production of reactive oxygen species, pro-inflammatory cytokines and growth factors by resident and infiltrating cells are associated with the development of tubulointerstitial lesions in both clinical and experimental models of DN [3,4,34].”
BackgroundThe Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932 · cited 2×
“Inflammatory cytokines, mainly interleukin 1(IL-1), interleukin 6 (IL-6), interleukin 8 (IL-8) and tumor necrosis factor a (TNFa) are involved in the development of and progression to interstitial fibrosis in both diabetic patients and experimental models [4,5].”
BackgroundDiverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652 · cited 1×
“In addition to cytokine production, induction of growth factors, such as insulin-like growth factor 1 (IGF-1), hepatocyte growth factor (HGF), transforming growth factor b (TGFb) and connective tissue growth factor (CTGF) in proximal tubules enhances the activation and proliferation of myofibroblasts and collagen depo…”
BackgroundSelf-citationThe proximal tubule in the pathophysiology of the diabetic kidney
Vallon, V. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00809.2010 · Cited by 395 · cited 1×
“Tubulointerstitial inflammation is a critical process in the development of diabetic nephropathy [1,3,5].”
BackgroundPatel, V., Li, L., Cobo-Stark, P., Shao, X., Somlo, S., Lin, F., & Igarashi, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn045 · Cited by 327 · cited 1×
“induced diabetic mice [35], the role of KKS in inflammatory pathways leading to DN is still controversial.”
BackgroundChung, A. C. K., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050510 · Cited by 268 · cited 1×
“Up-regulation of intercellular adhesion molecule 1 (ICAM-1) and chemokine (C-C motif) ligand 2 (CCL-2) leads to inflammatory cell recruitment and activation in the diabetic kidney [6].”
BackgroundSelf-citationImpaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Russo, L. M., Sandoval, R. M., Campos, S. B., Molitoris, B. A., Comper, W. D., & Brown, D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050503 · Cited by 261 · cited 1×
“tubules have been identified to be responsible for the change in urinary albumin excretion, which is independent of glomerular permeability changes during the very early stage of DN [13].”
Background
Research works printed but not linked: 1
- Tang SC, Chan LY, Leung JC, Cheng AS, Lan HY, et al.. (2011) Additive renoprotective effects of B2-kinin receptor blocker and PPAR-gamma agonist in uninephrectomized db/db mice. Lab Invest. 21537328 · DOI
Cited by
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Self-citationKallikreins – The melting pot of activity and function
Kalinska, M., Meyer-Hoffert, U., Kantyka, T., & Potempa, J. (2016) · Biochimie · doi:10.1016/j.biochi.2015.09.023 · Cited by 125
Magliocca, G., Mone, P., Iorio, B. R. D., Heidland, A., & Marzocco, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105354 · Cited by 138
Gut microbial metabolites SCFAs and chronic kidney disease
Meng, H., Wei, W., Zhang, Y., Xiang, Z., Peng, D., Kasimumali, A., & Rong, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04974-6 · Cited by 128
“…a downstream inflammatory cascade [62], activating the transcription factors NF-κB, AP-1, and p53, and promoting pro-inflammatory cytokine and chemokine production [63–65], further exacerbating the inflammatory state and promoting the disease progression of CKD [66] and renal fibrosis [67].”
BackgroundYiu, W. H., Wong, D. W. L., Wu, H., Li, R. X., Yam, I., Chan, L. Y. Y., Leung, J. C. K., Lan, H. Y., Lai, K. N., & Tang, S. C. W. (2015) · Kidney International · doi:10.1038/ki.2015.331 · Cited by 104
Self-citation
Metadata
- Authors
- Yiu, W. H., Wong, D. W. L., Chan, L. Y. Y., Leung, J. C. K., Chan, K. W., Lan, H. Y., Lai, K. N., & Tang, S. C. W.
- Affiliations
- Queen Mary Hospital (CN)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Tang, Sydney C. W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-21
- Volume
- 9
- Issue
- 2
- Pages
- e88894
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3931644
- OpenAlex
- W2038515422
- Cited by
- 50
- References
- 53
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 7 · 2015: 6
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- Funders
- American Society of Nephrology
- University of Hong Kong
- National Key Research and Development Program of China (2012CB517600, 2012CB517606)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- tissue kallikrein, KLK1, diabetic nephropathy, proximal tubular epithelial cells, PAR4, kallikrein-kinin system, inflammation, high glucose, advanced glycation end products, MAPK signaling, interleukin-8, ICAM-1, interleukin-6, MCP-1, connective tissue growth factor, type IV collagen, renal fibrosis, calcium mobilization, therapeutic target
- MeSH terms
- Analysis of Variance, Calcium, Cells, Cultured, Diabetes Mellitus, Enzyme-Linked Immunosorbent Assay, Epithelial Cells, Humans, Immunohistochemistry, Inflammation, Kidney Tubules, Proximal, Blotting, Western, Signal Transduction, Cytokines, Interleukin-8, DNA Primers, Receptors, Thrombin, Tissue Kallikreins, RNA Interference, RNA, Small Interfering, Receptors, Proteinase-Activated, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tissue Kallikrein Mediates Pro-Inflammatory Pathways and Activation of Protease-Activated Receptor-4 in Proximal Tubular Epithelial Cells. https://app.cochat.ai/papers/10.1371/journal.pone.0088894
- The paper
- Yiu, W. H., Wong, D. W. L., Chan, L. Y. Y., Leung, J. C. K., Chan, K. W., Lan, H. Y., Lai, K. N., & Tang, S. C. W. (2014). Tissue Kallikrein Mediates Pro-Inflammatory Pathways and Activation of Protease-Activated Receptor-4 in Proximal Tubular Epithelial Cells. PLoS ONE. https://doi.org/10.1371/journal.pone.0088894
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.